Determining the Necessity for Postoperative Antibiotics After Salivary Stent Placement
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03333408|
Recruitment Status : Recruiting
First Posted : November 6, 2017
Last Update Posted : March 21, 2019
|Condition or disease||Intervention/treatment||Phase|
|Salivary Duct||Drug: Postoperative Oral Antibiotics (Clindamycin or Augmentin)||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Determining the Necessity for Postoperative Antibiotics After Salivary Stent Placement|
|Actual Study Start Date :||June 15, 2018|
|Estimated Primary Completion Date :||September 2019|
|Estimated Study Completion Date :||November 2019|
Active Comparator: Group A (Antibiotic)
Group A will receive postoperative oral antibiotics for 10 - 14 days (Clindamycin or Augmentin) upon discharge.
Drug: Postoperative Oral Antibiotics (Clindamycin or Augmentin)
Patients will receive postoperative oral antibiotics (Clindamycin or Augmentin) for 10-14 days upon discharge.
No Intervention: Group B (no Antibiotic)
Group B will not be given postoperative oral antibiotics upon discharge.
- Post-operative infection [ Time Frame: 2 weeks ]The primary endpoint will be the determination of clinical infection between the time points post-operation to the 2 week follow-up visit when the stent is removed as indicated by evidence of purulence or erythema at the surgical site, fever and elevated white blood cell count.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03333408
|Contact: Rohan Walvekar, M.D.||email@example.com|
|Contact: Leslie Son, Ph.D.||firstname.lastname@example.org|
|United States, Louisiana|
|Our Lady of the Lake Regional Medical Center||Recruiting|
|Baton Rouge, Louisiana, United States, 70808|
|Contact: Christine LeBoeuf, DNP 225-765-5956 email@example.com|
|Principal Investigator:||Rohan Walvekar, M.D.||Our Lady of the Lake Regional Medical Center|